Amneal Pharmaceuticals Price Target Announced at $27.00/Share by Oppenheimer
Ratings actions from Benzinga: GMT) Amneal Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Amneal Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga